Liu Ying, Ganesan Trivadi S
ICRF Molecular Oncology Laboratories, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, UK.
Reproduction. 2002 Mar;123(3):341-53. doi: 10.1530/rep.0.1230341.
Ovarian cancer is the most frequent cause of death from gynaecological malignancies in the western world, and sporadic epithelial ovarian cancer is its most predominant form. The aetiology of sporadic ovarian cancer remains unknown. Genetic studies have enabled a better understanding of the evolution of tumour progression. A major focus of research has been to identify tumour suppressor genes implicated in sporadic ovarian cancer over the past decade. Several tumour suppressor genes have been identified by strategies such as positional cloning and differential expression display. Further research is warranted to understand fully their contribution to the pathogenesis of sporadic ovarian cancer.
在西方世界,卵巢癌是妇科恶性肿瘤致死的最常见原因,而散发性上皮性卵巢癌是其最主要的形式。散发性卵巢癌的病因尚不清楚。基因研究有助于更好地理解肿瘤进展的演变过程。在过去十年中,研究的一个主要重点是确定与散发性卵巢癌相关的肿瘤抑制基因。通过定位克隆和差异表达显示等策略已经鉴定出了几种肿瘤抑制基因。有必要进行进一步的研究以充分了解它们对散发性卵巢癌发病机制的贡献。